Skip to main
CL

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 36%
Buy 36%
Hold 21%
Sell 7%
Strong Sell 0%

Bulls say

Colgate-Palmolive has demonstrated a strategic increase in advertising as a percentage of sales, rising from 11.6% in 2021 to an anticipated 13.5% in 2024, reinforcing its commitment to brand awareness and market presence. The company has successfully achieved growth in both price and volume from the second quarter of 2023 through the third quarter of 2024, indicating strong sales performance. Additionally, with approximately 70% of its business derived from international sales, including a significant 45% from emerging markets, Colgate-Palmolive is well-positioned to capitalize on global demand across its diverse product lines.

Bears say

Colgate-Palmolive's gross margin experienced a decline of 75 basis points year-over-year in the second quarter of 2025, largely due to the impact of raw material inflation and tariffs. The dog food segment, represented by Hill's specialty products, faced a 2.8% decline in U.S. measured retail channels during the third quarter of 2025, further compounding worries amid prior declines and contrasting with only modest growth in shipments. Additionally, the company reported ongoing volume declines of 0.3% and 0.9% in the first and second quarters of 2025, despite achieving positive pricing growth, indicating potential challenges in maintaining demand in a competitive market.

Colgate-Palmolive (CL) has been analyzed by 14 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 36% recommend Buy, 21% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 14 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Dec 31, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $89.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $89.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.